Atlas Trials

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Clinical trial NCT03861702 · COMPLETED

Trial details

NCT number
NCT03861702
Sponsor
Nelson Yee
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Pancreatic Carcinoma(LAPC)
Start date
2020-09-02
Primary completion
2023-08-16
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.